Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Erica Villa(University of Modena and Reggio Emilia), Antonia D’Errico(Azienda USL di Bologna), Chiara Gozzi(Azienda Ospedaliero-Universitaria di Modena), Simone Lasagni(University of Modena and Reggio Emilia), Calogero Cammà(University of Palermo), Gabriele Melegari(Azienda Unita' Sanitaria Locale Di Modena), Alessandra Pivetti(University of Modena and Reggio Emilia), Lorenza Di Marco(University of Modena and Reggio Emilia), Mariagrazia Del Buono(University of Modena and Reggio Emilia), Mattia Riefolo(Azienda USL di Bologna), Nicola De Maria(University of Modena and Reggio Emilia), Ciro Celsa(Hammersmith Hospital), Federico Casari(University of Modena and Reggio Emilia), Valentina Zuccaro(University of Pavia), Marcello Bianchini(University of Modena and Reggio Emilia), F Turrini(Azienda Unita' Sanitaria Locale Di Modena), Dimitriy Arioli(Azienda Ospedaliero-Universitaria di Modena), Veronica Bernabucci(University of Modena and Reggio Emilia), Lucio Brugioni(Azienda Ospedaliero-Universitaria di Modena), Tommaso Trenti(Azienda Unita' Sanitaria Locale Di Modena), Elena De Santis(Azienda Unita' Sanitaria Locale Di Modena), A Curatolo(University of Modena and Reggio Emilia), Dante Romagnoli(University of Modena and Reggio Emilia), Barbara Lei(University of Modena and Reggio Emilia), Silvio Malaguti(Azienda Unita' Sanitaria Locale Di Modena), Raffaele Bruno(University of Pavia), Giovanni Pinelli(Azienda Unita' Sanitaria Locale Di Modena), Irene Cassaniti(Policlinico San Matteo Fondazione), Lucia Carulli(University of Modena and Reggio Emilia), Rosina Maria Critelli(University of Modena and Reggio Emilia), Alessandra Melegari(Azienda Unita' Sanitaria Locale Di Modena), Pietro Torricelli(University of Modena and Reggio Emilia), Filippo Schepis(University of Modena and Reggio Emilia), Elisabetta Bertellini(Azienda Unita' Sanitaria Locale Di Modena)
Cited by 59
Related Papers
A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma†
|Hepatology|2009|479
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
|Journal of Hepatology|2019|205
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2019|152